(Q38894148)

7 September 2017

title

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma (English)

1 reference

7 September 2017

Pengfei Zhang

1

1 reference

7 September 2017

Zhaoru Dong

2

1 reference

7 September 2017

Jiabin Cai

3

1 reference

7 September 2017

Chi Zhang

4

1 reference

7 September 2017

Zaozhuo Shen

5

1 reference

7 September 2017

Aiwu Ke

6

1 reference

7 September 2017

Dongmei Gao

7

1 reference

7 September 2017

Jia Fan

8

1 reference

7 September 2017

Guoming Shi

9

1 reference

7 September 2017

publication date

1 March 2015

1 reference

International Journal of Immunopathology and Pharmacology

7 September 2017

published in

1 reference

7 September 2017

volume

28

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

36-44

1 reference

7 September 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Hepatocellular carcinoma: current management and future trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Role of BRD4 in hematopoietic differentiation of embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0394632015572070

21 January 2018

Identifiers

DOI

10.1177/0394632015572070

1 reference

7 September 2017

1 reference